(Q36614517)
Statements
1 reference
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial (English)
1 reference
B Vincenzi
1 reference
D Santini
1 reference
C Rabitti
1 reference
R Coppola
1 reference
B Beomonte Zobel
1 reference
L Trodella
1 reference
G Tonini
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference